Navigation Links
At CPhI 2013, Trinity Labs Discusses Industry Challenges & Opportunities & Its 5-Day Turnaround Promise
Date:11/5/2013

FRANKFURT, Germany, Nov. 5, 2013 /PRNewswire/ -- At CPhI Worldwide in Frankfurt last week, executives from the contract analytical services company, Trinity Scientific, discussed the challenges and opportunities facing the pharmaceutical industry today. These interviews appear in a brief video produced by CPhI PharmaEvolution.com.

The pace of technology innovation, and increased and changing regulations, have resulted in both challenges and opportunities for contract service partners in the pharmaceutical industry today, said Tom Horner, Managing Director.

At the same time, these changes are driving increased demand for analytical services, he said. Trinity is responding to customer needs with a range of new capabilities, and guarantees a five-day turnaround time for projects, according to Shaheen Akhgar, Trinity's Commercial Manager.

Meanwhile, the company is adding new equipment and services to improve its customer support and help companies meet increasingly stringent regulations, particularly in the UK, said Hanna Coonagh, General Manager, Fleet Laboratories. The company will be adding new solid dose capacity by the first quarter of next year and is recruiting new staff.

To watch the video, please visit CPhI PharmaEvolution.com at www.pharmaevolution.com.

The DDD family of companies has expanded with the addition of Trinity Scientific, a standalone contract laboratory providing a range of analytical services to the pharmaceutical industry, including analytical testing, method development, and stability.

Contact:

Editorial
Agnes Shanley
Editor in Chief, CPhI Pharma Evolution
agnes.shanley@ubm.com

Marketing
Carly Cohen
Marketing Coor
'/>"/>

SOURCE CPhI Pharma Evolution
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Nektar to Announce Financial Results for the Third Quarter of 2013 on Thursday, November 7, 2013, After Close of U.S.-Based Financial Markets
2. VIRGOs Supplyside Health & Nutrition Network Announces Featured Speaker For Supplyside West 2013, Daniel Fabricant, PH.D., Director, Divison Of Dietary Supplement Programs, FDA
3. 200 Pharma Customers to Attend ChemOutsourcing September 17-19, 2013, NJ, USA
4. Nektar to Announce Financial Results for the Second Quarter of 2013 on Thursday, August 8, 2013, After Close of U.S.-Based Financial Markets
5. Fewer Venture Capital Dollars Invested Into Life Sciences Companies In Q1 2013, According To The MoneyTree Report
6. Food Recalls Driven by Companies Issuing Multiple Recalls in the First Quarter of 2013, According to Latest ExpertRECALL Index
7. Nektar to Announce Financial Results for the First Quarter of 2013 on Thursday, May 9, 2013, After Close of U.S.-Based Financial Markets
8. FDAnews Announces Medical Device Risk Management Conference, July 11-12, 2013, Boston, MA
9. KIMES 2013, Biggest Medical Exhibition Show in Asia!
10. Researchers Expect a Marginal Increase in Laboratory Product Budgets for 2013, Finds Frost & Sullivan
11. Vermillion to Discuss Preliminary Results for Fourth Quarter and Full Year 2012 on Wednesday, February 20, 2013, at 4:30 p.m. ET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Research and Markets ... the "Dental Consumables Market - Global Industry ... - 2018" report to their offering. ... ) Dental consumables are products which are ... impairments, for tooth restoration and in treatment of ...
(Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading ... company, awarded several new IT value-added reseller (VAR) ... hospital organizations with IT goods and services at ... agreements, as well as value-added services such as ... New Novation agreements were awarded to ...
(Date:1/15/2014)... DUBLIN , January 15, 2014 ... that it has waived the Office of Fair Trading (OFT) ... the outstanding shares of ViroPharma Incorporated (NASDAQ: VPHM).   ... no longer conditional on OFT approval, and Shire expects to ... currently scheduled expiration time, subject to the satisfaction of all ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
... Reaffirms Primacy and Safety of ,First Generation, Antisense, ... (Nasdaq: GNTA ) announced the presentation of ... lead anticancer,compound, can be safely administered in high ... data were presented by Dr. Anthony Tolcher, Director,of ...
... - Studies Show Improvement in Hemodynamics and Delay ... Actelion Pharmaceuticals US, Inc.,today announced positive results from ... and effective as a combination therapy,for the treatment ... suggest that Tracleer, when given in combination with ...
Cached Medicine Technology:Genasense(R) Can be Administered by Brief High-Dose IV Infusion 2Genasense(R) Can be Administered by Brief High-Dose IV Infusion 3Genasense(R) Can be Administered by Brief High-Dose IV Infusion 4Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension 2Tracleer(R) Shows Clinical Benefit as Combination Therapy with Sildenafil for Pulmonary Arterial Hypertension 3
(Date:4/14/2014)... treat children with uncomplicated acute appendicitis is a reasonable ... fewer missed school days, according to a pilot study. ... Hospital and published online April 12 in the ... the first prospective study on nonoperative management of acute ... , Researchers enrolled 77 patients age 7 to 17 ...
(Date:4/14/2014)... 2014, Perth, Australia. Drug discovery company Proteomics International ... of a companion diagnostic (CDx) test with the ... The research team authenticated the panel of biomarkers ... samples. Seven biomarkers were validated at high stringency ... The mass spectrometry data was then cross-validated using ...
(Date:4/14/2014)... 2014) When it comes to the cost and ... Patients get the best care when they are treated ... extensive experience in their current job, according to a ... and Columbia Business School. The study was published in ... Applied Economics . , The review of more ...
(Date:4/13/2014)... STANFORD, Calif. A low-cost empowerment program for ... and sexual harassment of these girls, who live ... and are frequently attacked, a large new study ... Stanford University School of Medicine, Lucile Packard Children,s ... No Worldwide, validated the program,s effectiveness in combating ...
(Date:4/11/2014)... the processes that control brain cell production could pave ... brain-related disorders. , Scientists have gained new understanding of ... how and when nerve and brain cells are formed ... and keeps it healthy. Their findings could help explain ... which is a fundamental characteristic of many diseases including ...
Breaking Medicine News(10 mins):Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4
... WASHINGTON and NEWARK, N.J., March 4 ,Cathedral Healthcare ... States $5.3,million, plus interest, to settle allegations that ... announced today., The settlement resolves allegations that ... Medicare patients in order,to obtain enhanced reimbursement from ...
... Secretary Mike,Leavitt and the Secretary of Health of ... a Memorandum of Understanding (MOU) today,strengthening cross-border cooperation ... plan to work together on common health,problems. The ... in public,health; the document signed today updates a ...
... risk in post-menopausal women after they stopped taking combined ... that will be reported in the March 5 edition ... said Rowan T. Chlebowski, M.D., Ph.D., a Los Angeles ... to the study. , This latest study reinforces the ...
... DARA BioSciences(TM),(Nasdaq: DARA ) announced today the ... of Directors. Dr. Drutz was appointed to fill ... Compensation Committee as well as Corporate,Governance and Nominating ... Richard Franco, Sr., DARA,s Board Chairman, commented, "It ...
... (Nasdaq: ISTA ), today announced it will release ... the U.S. markets close. ISTA will,host a conference call, ... a commercial and pipeline update at 5:00 p.m. Eastern,Time ... call, U.S. and Canadian participants may,dial 866-831-6270; international participants ...
... to continued need for mammograms , , TUESDAY, March 4 (HealthDay ... a woman stops taking combination hormone replacement therapy, a new ... 5 issue of the Journal of the American Medical ... Health Initiative (WHI). That trial was halted abruptly in 2002, ...
Cached Medicine News:Health News:Cathedral Healthcare System to Pay U.S. $5.3 Million to Resolve Allegations Involving Inflated Charges to Obtain Higher Medicare Reimbursement 2Health News:United States and Mexico Renew Agreement on Cooperation in Health 2Health News:LA BioMed researcher says 'unexpected' increase in cancer risk found 2Health News:DARA BioSciences, Inc. Announces Appointment of Dr. David J. Drutz to Board 2Health News:Raised Breast Cancer Risk Persists After Combo HRT Stopped 2Health News:Raised Breast Cancer Risk Persists After Combo HRT Stopped 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: